Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...

Concomitant ixekizumab and tirzepatide significantly improved skin clearance and weight reduction in adults with moderate to severe plaque psoriasis.

At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...

Eli Lilly (LLY) stock is in focus as Zepbound succeeds in a late-stage trial for patients with plaque psoriasis. Read more ...

COMMISSION on Filipinos Overseas (CFO) Secretary Dante Ang II vowed to help protect the integrity of Philippine schools in the United Arab Emirates (UAE). Ang raised the need to enhance the ...

With their blockbuster obesity drugs, Eli Lilly and Novo Nordisk have uncovered a variety of ailments the incretin treatments can combat. | Six weeks after Eli Lilly revealed the success of phase 3b ...

After days of selling pressure, positive sentiments returned at the Pakistan Stock Exchange (PSX), with the benchmark KSE-100 ...

Trading kicked off at the Pakistan Stock Exchange (PSX) on a positive note amid days of selling pressure, with the benchmark ...

Bears tightened their grip on the Pakistan Stock Exchange (PSX) on Tuesday as foreign corporate selling continued, sending ...

Eli Lilly and Co. LLY on Wednesday shared topline results from the landmark TOGETHER-PsO open-label Phase 3b trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

Merck , known as MSD outside of the U.S. and Canada, and Mayo Clinic, the world's top-ranked hospital system, today announced a research and development agreement to apply artificial intelligence (AI) ...

Dozens of flights are delayed or cancelled amid a winter storm dumping freezing rain and ice pellets on the GTA.